retatrutide clinical trial weight loss results 📈 PHASE 3 RESULTS: BY THE NUMBERS Let's break down what the trials actually showed: SURMOUNT-1 (68 weeks): • Average loss: 24% of body weight • Participants Retatrutide just posted Phase 3

Youre only permitted a very small amount of daily carbohydrate, one of the three primary macronutrients (alongside protein and fat)

The hidden impact of GLP-1 receptor agonists on endometrial function and female fertility

Understanding GLP-1 qualification criteria and BMI requirements for GLP-1 therapy can also be relevant if you are considering switching medications or adjusting your treatment plan

It's one more reason why I am not here to scare you off these medications

According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported side effects include nausea, vomiting, diarrhoea, abdominal pain, and constipation

" More research is needed into why and how these taste change vary across individuals as GLP-1s become an increasingly mainstream option for weight loss, Doty and other experts say especially as use among Americans has more than doubled in the past year